Race Oncology Ltd (RAC) is an Australian pharmaceutical company whose business model is to pursue and bring to market later stage assets, principally in the cancer field. The Company’s first important asset is a chemotherapy drug, called Bisantrene, which was the subject of more than 40 phase II clinical studies.
Race Oncology Ltd belongs to Health Care sector and under industry of Biotechnology. You can get more information about this company via their website: http://www.raceoncology.com.
This a small cap company with market cap of 553 millions.
Compared to Market and Sector
The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.
Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.
Dividend Growth Chart
The following chart shows you how rac dividend grows in the recent years.